Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MPR”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Large-scale testing (Phase 3)Study completedNCT01093196
What this trial is testing

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 660
Large-scale testing (Phase 3)Looking for participantsNCT06925243
What this trial is testing

Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 682
Not applicableStudy completedNCT04593381
What this trial is testing

Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsRecurrent Ovarian CarcinomaOligometastatic Disease
Gemelli Molise Hospital 376
Large-scale testing (Phase 3)Active Not RecruitingNCT00602641
What this trial is testing

Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 306
Testing effectiveness (Phase 2)Looking for participantsNCT06353685
What this trial is testing

De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.

Who this might be right for
De-escalated Radiotherapy; Head and Neck Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 103
Testing effectiveness (Phase 2)Study completedNCT00396045
What this trial is testing

Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Turin, Italy 54
Large-scale testing (Phase 3)Study completedNCT00405756
What this trial is testing

Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.

Who this might be right for
Newly Diagnosed Multiple Myeloma
Celgene Corporation 459
Post-approval studies (Phase 4)Not Yet RecruitingNCT06785584
What this trial is testing

Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study

Who this might be right for
ALK-positive Advanced NSCLCALK-positive Non-small Cell Lung Cancer (NSCLC)MPR+1 more
Fujian Medical University Union Hospital 30
Not applicableStudy completedNCT00414297
What this trial is testing

External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Insel Gruppe AG, University Hospital Bern 30
Not applicableLooking for participantsNCT07309718
What this trial is testing

MPR for Stroke Risk Assessment of ICAS

Who this might be right for
ICAS - Intracranial AtherosclerosisStroke IschemicHemodynamic
Xuanwu Hospital, Beijing 400
Not applicableStudy completedNCT01890018
What this trial is testing

Partners and Alerts: A Study of Social Forces in Medication Adherence

Who this might be right for
Acute Myocardial Infarction (AMI)
University of Pennsylvania 178
Testing effectiveness (Phase 2)Looking for participantsNCT06208826
What this trial is testing

A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy

Who this might be right for
Head and Neck Cancer
Tianjin Medical University Cancer Institute and Hospital 268
Large-scale testing (Phase 3)Study completedNCT00551928
What this trial is testing

Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaNewly Diagnosed Patients
Fondazione EMN Italy Onlus 402
Not applicableStudy completedNCT03112928
What this trial is testing

Phantom Motor Execution Via MPR, VR/AR, and SG, as a Treatment of PLP

Who this might be right for
Phantom Limb Pain
Integrum 77
Not applicableLooking for participantsNCT05854823
What this trial is testing

The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 23
Testing effectiveness (Phase 2)Study completedNCT01160107
What this trial is testing

Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 46
Large-scale testing (Phase 3)Looking for participantsNCT06949033
What this trial is testing

Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 668
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07090707
What this trial is testing

PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)

Who this might be right for
HNSCCPD-1Radiotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50
Not applicableUnknownNCT00134225
What this trial is testing

Study to Demonstrate That Muscle Pattern Recognition (MPR) is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain

Who this might be right for
Neck PainLow Back Pain
iTech Medical, Inc. 480
Testing effectiveness (Phase 2)Ended earlyNCT03968419
What this trial is testing

This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 88